BioPharmSignal logoBioPharmSignal

Biotech News

Journey Medical Corporation to Participate in October 2025 Investor Conferences

Journey Medical Corporation (DERM)Journey Medical CorporationCompany update

DERM (DERM) appears in the live feed after a catalyst-style update. The headline is surfaced in real time so readers can move from signal to source without leaving the product flow.

The source domain is derm.com. BioPharmSignal keeps the ticker, timestamp, and source together for faster review before the wider market catches up.

The original release is available below in a new tab so readers can continue into the full source when needed.

Related news

DERMJourney Medical Corporation2025-09-03 12:30 EST

Journey Medical Corporation to Participate in September 2025 Investor Conferences

DERMJourney Medical Corporation2026-05-19 20:45 EST

Journey Medical Corporation to Participate in A.G.P.’s Annual Virtual Healthcare Conference

View all latest news

Journey Medical Corporation

Prescription Dermatology Company Journey Medical develops, acquires, and commercializes FDA-approved prescription products for dermatologic conditions through a specialist sales organization. Emrosi Emrosi is the company’s newer treatment for inflammatory lesions of rosacea and is central to its current commercial expansion. Established...

Recent company news

DERMJourney Medical Corporation2026-08-05 12:30 EST

Journey Medical Corporation to Announce Second Quarter 2026 Financial Results on August 12, 2026

DERMJourney Medical Corporation2026-05-19 20:45 EST

Journey Medical Corporation to Participate in A.G.P.’s Annual Virtual Healthcare Conference

DERMJourney Medical Corporation2026-05-13 20:01 EST

Journey Medical Corporation Reports First Quarter 2026 Financial Results and Recent Corporate Highlights

DERMJourney Medical Corporation2026-05-06 20:01 EST

Journey Medical Corporation to Announce First Quarter 2026 Financial Results on May 13, 2026

DERMJourney Medical Corporation2026-04-21 12:30 EST

Journey Medical Corporation Secures Contract with Third Major GPO for Emrosi™

Stock data

Close
6.53 USD
Market cap
165.76M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States